Several members of the transforming growth factor β (TGFβ) family suppressed the growth of primary AML cells (144), and blockade of TGFβ was therefore thought to enhance chemotherapy sensitivity of AML cells (Table 1). Here, TGFB1 is linked to acute myeloid leukemia.